Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy

HIV Medicine

Volumn 7, Issue 5, 2006, Pages 291-293

  Palmieri, C ^a   Dhillon, T ^a   Thirlwell, C ^a   Newsom Davis, T ^a   Young, A M ^a   Nelson, M ^a   Gazzard, B G ^a   Bower, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

AIDS; HAART; HIV; Pulmonary Kaposi sarcoma

Indexed keywords

ANTHRACYCLINE; ANTIRETROVIRUS AGENT;

ADULT; AFRICA; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RANK SUM TEST; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONDON; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; SURVIVAL ANALYSIS;

EID: 33744464057     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00378.x     Document Type: Article

References (16)

1. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11: 1731-1738.
2. Dupon M, Marimoutou C, Cazorla C et al. Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-96. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Int J Epidemiol 1998; 27: 1078-1082.
3. International Collaboration on HIV & Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 1823-1830.
4. Bower M, Fox P, Fife K, Gill J, Nelson M, Gazzard BG. HAART prolongs time to treatment failure (TTF) in Kaposi's sarcoma. J Acquir Immune Defic Syndr 1999; 21: A24.
5. Lebbe C, Blum L, Pellet C et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 1998; 12: 45-49.
6. Jacobson LP, Yamashita TE, Detels R et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1999; 21 (Suppl. 1): 34-41.
7. Portsmouth S, Stebbing J, Gill J et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 2003; 17: 17 -22.
8. Aboulafia DM. The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 2000; 117: 1128 -1145.
9. Kaplan LD, Hopewell PC, Jaffe H, Goodman PC, Bottles K, Volberding PA. Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988; 1: 23-30.
10. Gill PS, Akil B, Colletti P et al. Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 1989; 87: 57-61.
11. Cadranel JL, Kammoun S, Chevret S et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994; 49: 958-960.
12. Garay SM, Belenko M, Fazzini E, Schinella R. Pulmonary manifestations of Kaposi's sarcoma. Chest 1987; 91: 39-43.
13. Meduri GU, Stover DE, Lee M, Myskowski PL, Caravelli JF, Zaman MB. Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations. Am J Med 1986; 81: 11-18.
14. Hannon FB, Easterbrook PJ, Padley S, Boag F, Goodall R, Phillips RH. Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patients. Int J STD AIDS 1998; 9: 518-525.
15. Holkova B, Takeshita K, Cheng DM et al. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol 2001; 19: 3848-3851.
16. Dupin N, Rubin De Cervens V, Gorin I et al. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. Br J Dermatol 1999; 140: 875-881.